
Loading, please wait...

Loading, please wait...

A simple oral mucosal lesion can conceal severe systemic disease. In modern medical practice, clinicians frequently treat pharyngeal complaints as self-limiting viral infections or primary mucosal ulcerations. However, an atypical oral plaque in a patient living with human immunodeficiency virus (HIV) can uncover occult treponemal dissemination. Clinicians must recognize that asymptomatic neurosyphilis frequently develops during the early phases of secondary syphilis. This article examines a critical case where an isolated oropharyngeal sore guided clinicians toward an occult central nervous system infection.
Oral lesions represent uncommon manifestations of secondary syphilis, yet they serve as essential diagnostic indicators for discerning clinicians. In this notable clinical case, a 29-year-old man who has sex with men presented with localized throat pain. The patient had recently received a new diagnosis of HIV infection. Physical examination revealed an irregular, greyish-white plaque surrounded by prominent erythematous margins on the soft palate and extending into the oropharynx. Consequently, initial suspicion focused on common mucosal opportunistic processes, including candidiasis, viral ulcerations, or secondary bacterial infections.
Standard microbiological investigations produced entirely negative cultures, which prompted wider serological testing. Secondary syphilis classically produces mucous patches that appear as painless or mildly tender, flat, glistening white or grey erosions. Because these mucosal patches teem with virulent spirochetes, they carry high infectivity. In this patient, quantitative syphilis serology demonstrated a marked Venereal Disease Research Laboratory titre of 1:128 alongside a reactive Treponema pallidum hemagglutination assay. Therefore, the clinical team established a diagnosis of secondary syphilis with atypical oral involvement, successfully clearing the lesion using standard intramuscular benzathine penicillin.
Historically, medical textbooks taught that neurosyphilis developed exclusively decades after initial primary infection as a late tertiary complication. Modern infectious disease research completely contradicts this outdated paradigm. Treponema pallidum readily crosses the blood-brain barrier within days to weeks after initial inoculation. Thus, spirochetes regularly invade the meninges and cerebrospinal fluid compartments during primary and secondary stages. In immunocompetent hosts, active cell-mediated immunity frequently clears transient central nervous system seeding without long-term consequences.
Conversely, concurrent HIV infection severely undermines this natural treponemal clearance mechanism. Defective cellular immunity allows spirochetes to persist and proliferate unchecked within the subarachnoid space. As a direct result, asymptomatic neurosyphilis establishes itself silently within vulnerable neural structures. Patients exhibit completely normal neurological, cognitive, and sensory examinations despite active leptomeningeal inflammation. If clinicians leave this hidden treponemal reservoir untreated, the ongoing subclinical inflammation eventually progresses into irreversible meningovascular strokes, general paresis, or tabes dorsalis. Therefore, identifying asymptomatic neurosyphilis during early stages prevents devastating long-term neurological disability.
Evaluating patients for occult central nervous system involvement requires rigorous clinical stratification. In this case, the medical team pursued immediate cerebrospinal fluid examination despite a completely normal neurological examination. Two pivotal clinical risk factors justified this invasive lumbar puncture: coinfection with HIV and a very high baseline serum non-treponemal titre of 1:128. Established epidemiological evidence demonstrates that serum titres exceeding 1:32 correlate strongly with treponemal dissemination into the neural axis.
The patient's cerebrospinal fluid analysis revealed marked lymphocytic pleocytosis, elevated protein concentrations, and a reactive cerebrospinal fluid non-treponemal antibody assay. A reactive cerebrospinal fluid Venereal Disease Research Laboratory test provides definitive confirmation of neurosyphilis because the test exhibits exceptionally high specificity. Although negative results cannot fully exclude neural invasion due to modest sensitivity, a positive result eliminates diagnostic ambiguity. Consequently, these laboratory findings established a conclusive diagnosis of asymptomatic neurosyphilis, proving that silent neural inflammation can parallel early cutaneous or mucosal manifestations.
Selecting appropriate antimicrobial therapy demands absolute clinical vigilance when managing neurosyphilis. Standard intramuscular benzathine penicillin G effectively cures cutaneous and mucosal secondary syphilis. Indeed, the patient experienced complete mucosal resolution of his oropharyngeal plaque following initial intramuscular administration. However, benzathine penicillin produces virtually undetectable treponemicidal concentrations within the cerebrospinal fluid. Therefore, relying solely on standard intramuscular regimens leaves active spirochetes within the central nervous system, creating severe risks for therapeutic failure.
Guidelines mandate high-dose intravenous crystalline penicillin G as the definitive treatment of choice for all neurosyphilis cases, regardless of visible symptoms. Clinicians administer 18 to 24 million units daily, divided into 3 to 4 million units intravenously every four hours or delivered via continuous intravenous infusion for 10 to 14 consecutive days. Alternatively, outpatient regimens combine intramuscular procaine penicillin with oral probenecid under strict adherence monitoring. Following completion of intravenous therapy, clinicians must perform serial quantitative serological monitoring at 3, 6, and 12 months. Furthermore, persistence of abnormal non-treponemal titres warrants repeat lumbar puncture to verify neurochemical resolution.
This remarkable case delivers invaluable practical guidance for physicians practicing in diverse clinical environments. First, physicians must never dismiss atypical pharyngeal or oral lesions as mundane complaints, especially in sexually active individuals. Clinicians should maintain a high index of suspicion for syphilis when encountering unexplained oral ulcers or mucosal plaques. Because secondary syphilis mimics numerous dermatological and oral diseases, immediate serological screening remains mandatory.
Second, clinicians must actively evaluate neurosyphilis risk in all patients presenting with concurrent syphilis and HIV infection. Rather than waiting for overt cranial neuropathies, cognitive decline, or focal deficits, teams must proactively consider diagnostic lumbar puncture. Specifically, individuals with high non-treponemal titres, depressed CD4 cell counts, or incomplete serological responses require neurochemical evaluation. Ultimately, rigorous early detection and aggressive intravenous penicillin therapy eliminate preventable neurological morbidity in high-risk populations.
Asymptomatic neurosyphilis produces no overt neurological complaints or physical examination abnormalities. Consequently, clinicians must rely on surrogate epidemiological and laboratory indicators. Key predictive markers include concurrent HIV infection, a baseline peripheral blood CD4 count below 350 cells per microlitre, and high serum non-treponemal titres exceeding 1:32. Whenever high-risk patients present with secondary lesions like oral plaques, physicians must suspect silent central nervous system invasion.
Clinicians must perform an immediate lumbar puncture whenever a patient with syphilis presents with visual changes, hearing loss, or neurological symptoms. Additionally, international guidelines support diagnostic lumbar puncture in neurologically intact patients who have concurrent HIV infection alongside serum non-treponemal titres equal to or exceeding 1:32. Physicians should also evaluate cerebrospinal fluid if patients experience serological non-response or clinical relapse following standard antimicrobial therapy.
Intramuscular benzathine penicillin G creates slow, low-level systemic release that successfully eradicates Treponema pallidum in vascular tissues and skin. However, the molecule fails to penetrate the blood-brain barrier in concentrations sufficient to kill spirochetes inside cerebrospinal fluid. Therefore, clearing neural infection requires high-dose aqueous crystalline penicillin G given intravenously every four hours for 10 to 14 days to achieve robust bactericidal levels.
Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.
References
Nukala PK et al. An unexpected diagnosis behind a simple oral sore: asymptomatic neurosyphilis. Trans R Soc Trop Med Hyg. 2026 Nov 18. doi: undefined. PMID: 43046894.
Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis. 2004;189(3):369-376.
Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A routine oral sore can conceal severe treponemal central nervous system invasion. This case highlights how an isolated oral mucous patch in a newly diagnosed HIV patient revealed asymptomatic neurosyphilis, underscoring the urgent necessity of targeted cerebrospinal fluid analysis in high-risk individuals.
Today

A landmark SEER-Medicare study clarifies the breast cancer screening benefit in women aged 70 and 75. Life-years gained vary significantly based on comorbidity, frailty, and race, highlighting why physicians must personalize screening decisions rather than relying solely on arbitrary chronological age cutoffs.
Today

A new scoping review and expert consensus establish a concise 16-measure performance bundle for hospital cardiology services. Covering clinical processes, outcomes, patient-reported experiences, and structural factors, this framework advances value-based cardiovascular care under universal health coverage.
Today

A biomechanical evaluation compares crossed headed versus headless compression screws in first TMTJ arthrodesis. Both constructs provide comparable stiffness and angular stability, while headless screws reduce hardware prominence and headed screws show higher ultimate load.
Today

A secondary analysis of the Living Healthier with Diabetes trial reveals that positive baseline technology attitudes significantly improve engagement with digital diabetes self-management apps, leading to enhanced self-care behaviors and better long-term glycemic control in adults with type 2 diabetes.
Today